Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.001 | uM | 8 | 2500.00 | 1344.63 | 3893.00 | 3809.50 | 1.0219 | 1.0291 |
| BT-20 | Lapatinib | 10 | uM | 8 | 2500.00 | 1344.63 | 2168.00 | 3809.50 | 0.5691 | 0.3743 |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3887.00 | 3809.50 | 1.0203 | 1.0270 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3934.00 | 3809.50 | 1.0327 | 1.0433 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 2500.00 | 1344.63 | 3681.00 | 3809.50 | 0.9663 | 0.9548 |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3745.00 | 3809.50 | 0.9831 | 0.9774 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3209.00 | 3809.50 | 0.8424 | 0.7842 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 2953.00 | 3809.50 | 0.7752 | 0.6882 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3133.00 | 3809.50 | 0.8224 | 0.7560 | |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 2500.00 | 1344.63 | 3446.00 | 3809.50 | 0.9046 | 0.8709 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 2500.00 | 1344.63 | 2903.00 | 3809.50 | 0.7620 | 0.6691 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 2500.00 | 1344.63 | 1058.00 | 3809.50 | 0.2777 | -0.1475 |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 2500.00 | 1344.63 | 2409.00 | 3809.50 | 0.6324 | 0.4742 |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 2500.00 | 1344.63 | 3830.00 | 3809.50 | 1.0054 | 1.0072 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 2500.00 | 1344.63 | 3858.00 | 3809.50 | 1.0127 | 1.0169 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 2500.00 | 1344.63 | 3865.00 | 3809.50 | 1.0146 | 1.0193 |
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 2500.00 | 1344.63 | 1427.00 | 3809.50 | 0.3746 | 0.0404 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 2500.00 | 1344.63 | 3982.00 | 3809.50 | 1.0453 | 1.0598 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 2500.00 | 1344.63 | 4112.00 | 3809.50 | 1.0794 | 1.1044 |
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 2500.00 | 1344.63 | 4129.00 | 3809.50 | 1.0839 | 1.1101 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 2500.00 | 1344.63 | 4063.00 | 3809.50 | 1.0665 | 1.0876 |
| BT-20 | 17-AAG | 0.01 | uM | 8 | 2500.00 | 1344.63 | 3369.00 | 3809.50 | 0.8844 | 0.8429 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 2500.00 | 1344.63 | 4194.00 | 3809.50 | 1.1009 | 1.1322 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 2500.00 | 1344.63 | 3986.00 | 3809.50 | 1.0463 | 1.0612 |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 2500.00 | 1344.63 | 1217.00 | 3809.50 | 0.3195 | -0.0642 |